MedTrace Logo

Glyceryl Eicosapentaenoate Based Topic Products as an Irritant-free Cream and Serum for Hydration of Sensitive Skin

NCT06219213 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2026-04-21

No results posted yet for this study

Summary

This exploratory study aims to verify the hydrating potential as well as the possible irritant effects of a 14-day hydrating treatment consisting of daily application of serum and cream to the skin of two dry targeted areas. Thirty-three (33) subjects will be enrolled in this study and will be divided into three different treatment groups of 11 subjects each. Apart from the formulation of the cream which varies between the three groups, the subjects will receive the same serum and adhere to the same study plan for fourteen days. Each subject's baseline condition before treatment will serve as a control for effects observed after treatment on targeted areas.

Conditions

  • Skin Dryness

Interventions

OTHER

Glyceryl Eicosapentaenoate serum

Daily application of serum on both targeted skin areas for 14 consecutive days. Serum must be applied before the Cream on clean skin.

OTHER

Glyceryl Eicosapentaenoate Cream A

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

OTHER

Glyceryl Eicosapentaenoate Cream B

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

OTHER

Glyceryl Eicosapentaenoate Cream C

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

Sponsors & Collaborators

  • SCF Pharma

    lead INDUSTRY

Principal Investigators

  • Samuel Fortin, Ph.D · SCF Pharma

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2025-11-05
Completion
2025-11-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06219213 on ClinicalTrials.gov